Sam Chun Dang Pharm. Co., Ltd
KOSDAQ:A000250
111,700.00
₩-,100.00 (-0.09%)
111,700.00
₩-,100.00 (-0.09%)
End-of-day quote: 05/14/2024

Sam Chun Dang Pharm. financials at a glance

The revenue of Sam Chun Dang Pharm. is reported as 166.86233 billion Won in the fiscal year 2023. The earnings were -45 Won per share in 2023, which was 0 higher than 2020. And about -5.46729 billion Won are reported as free cash flow in the financials of Sam Chun Dang Pharm. 2023. No dividends were paid to the shareholders of the Sam Chun Dang Pharm. stock KOSDAQ:A000250 in the financial year 2023.

₩166.86B
Revenue
₩-45.00
Earnings Per Share
50.14%
Gross Margin %
₩0.00M
Free Cash Flow
Revenue
166,862.33
Earnings Per Share
-45.00
Gross Margin %
50.14
Free Cash Flow
0.00

Financials

Year Year TTM 2023 2020 2019 2016 2015 2014 2013 2012
Rev. Revenue N/A ₩166.86B ₩166.86B ₩186.60B ₩147.37B ₩132.06B ₩119.00B ₩104.54B ₩0.00M
GM % Gross Margin % 50.64% 50.14% 56.20% 59.21% 53.54% 54.40% 54.70% 53.97% 49.46%
OM Operating Margin 5.04% 4.96% 2.58% 13.51% 16.53% 15.73% 15.93% 15.17% 7.12%
EPS Earnings Per Share ₩-,681.43 ₩-45.00 ₩-45.00 ₩488.00 ₩413.00 ₩553.00 ₩572.00 ₩449.00 ₩69.00
Div. Dividends N/A ₩0.00 ₩0.00 ₩50.00 ₩50.00 ₩50.00 ₩75.00 ₩0.00 ₩0.00
PR % Payout Ratio % 0 -0.00% -0.00% 10.25% 12.11% 9.04% 13.11% 0 0
Sha. Shares N/AM 22.76M 22.07M 21.41M 21.3M 20.54M 20.35M 19.3M 19.3M
OCF Operating Cash Flow N/A ₩3.25B ₩3.25B ₩30.60B ₩17.76B ₩17.34B ₩14.13B ₩0.00M ₩0.00M
FCF Free Cash Flow N/A ₩-5,467.29M ₩-5,429.09M ₩24.01B ₩13.66B ₩8.69B ₩5.42B ₩0.00M ₩0.00M
FCFS Free Cash Flow Per Share ₩-1,162.93 ₩64.87 ₩-,394.53 ₩1.00k ₩424.28 ₩328.42 ₩442.67 ₩582.64 ₩-93.19